Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

Blood (2023) 142 (Supplement 1): 4933.

https://doi.org/10.1182/blood-2023-185757

Published: 2023

Journal Articles

Allogeneic STEM Cell Transplantation in 45 Patients with Myelodysplastic Syndrome: Single-Center Analysis

Helena Pomares, Rocio Parody Porras, Alberto Mussetti, Mercedes Galiano, Clara Maluquer, Anna Sureda, Montserrat Arnan

Blood (2021) 138 (Supplement 1): 4913.

https://doi.org/10.1182/blood-2021-153333

Published: 2021

Journal Articles

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Per Ljungman, MD PhD, Rafael De La Camara, MD, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, MD, Yves Beguin, MD PhD, Rodrigo Martino Bufarull, Fabio Ciceri, MD, Lucía López Corral, MD, Claudia Crippa, MD, Dries Deeren, MD PhD, Rafael F. Duarte, MD PhD FRCP, María Laura Fox, Anna Grassi, MD, María-José Jimenez, MD, Safiye Koculu, MD, Mi Kwon, MD PhD, Juan Carlos Vallejo Llamas, Jose Luiz Lopez Lorenzo, MD, Stephan Mielke, MD, Javier López Jiménez, MD PhD, Zoraida Mesa Morales, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Rocio Parody Porras, Victoria Potter, MBBS, BSc, FRACP, FRCPA, María Suárez-Lledó, MD, Nicolaas Schaap, MD PhD, Celestine Simand, MD, Luisa Sisinni, MD, John A Snowden, MD PhD, Daniele Vallisa, MD, Ipek Yonalhindilerden, Alienor Xhaard, MD, Nina Simone Knelange, Angel Cedillo, Nicolaus Kröger, MD, Jose Luis Piñana Sanchez, Jan Styczynski, MD PhD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-138732

Published: 2020

Journal Articles

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic

Alberto Mussetti, MD, Maria Queralt Salas Gay, MD, Maria Condom, MD, Maite Antonio, MD PhD, Cristian Ochoa, Iulia Ivan, David Jiménez Ruiz De La Torre, MD, Gabriela Isabel Sanz-Linares, MD, Belen Ansoleaga, Rocio Parody, MD, Ali Bazarbachi, MD PhD, Anna Sureda Balari, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-138780

Published: 2020

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-137773

Published: 2020

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

Blood (2019) 134 (Supplement_1): 3325.

https://doi.org/10.1182/blood-2019-126507

Published: 2019

Journal Articles

A High Dose of Naïve CD8 + T-Cells Increases the Incidence of Graft-Versus-Host Disease (GvHD) after Donor Lymphocyte Infusions (DLIs) from HLA Identical Sibling Donors

Guillermo Ortí, Carlos Palacio, Irene García-Cadenas, Isabel Sánchez-Ortega, María-José Jimenez, MD, Carmen Azqueta, Guillermo Villacampa, Christelle M Ferra, Rocio Parody, Rodrigo Martino, Francesc Bosch, MD PhD, David Valcarcel, Sergio Querol

Blood (2019) 134 (Supplement_1): 3292.

https://doi.org/10.1182/blood-2019-124358

Published: 2019

Journal Articles

Influence of VDR Polymorphisms on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) within the Alovita Trial.

Estrella Carrillo-Cruz, MD, Teresa Caballero-Velázquez, MD PhD, Isabel Montero, MD, Fermin Sanchez-Guijo, MD PhD, Miguel Alcoceba, PhD, Christelle Marie Ferra I Coll, David Valcarcel, Rocio Parody, MD, Lucia Lopez Corral, Oriana López-Godino, Marian Cuesta, Francisco Marquez, Teresa Ramos, José Raúl Garcia-Lozano, José A. Pérez-Simón

Blood (2017) 130 (Supplement 1): 3251.

https://doi.org/10.1182/blood.V130.Suppl_1.3251.3251

Published: 2017

Journal Articles

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

Blood (2017) 130 (Supplement 1): 3273.

https://doi.org/10.1182/blood.V130.Suppl_1.3273.3273

Published: 2017

Journal Articles

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Blood (2017) 130 (Supplement 1): 1983.

https://doi.org/10.1182/blood.V130.Suppl_1.1983.1983

Published: 2017

Journal Articles

Non-Cryopreserved Autologous Hematopoietic Transplantation Has Less Short Term Complications, Faster Engraftment and Similar Transplant Outcomes Than Cryopreserved Modality in Multiple Myeloma and Lymphoma Patients. a Comparative Analysis of Two Centers

Mauricio Sarmiento, MD, Rocio Parody, MD PhD, Queralt Salas, MD, Nicole Beffermann, MD, Veronica Jara, RN, Pablo A Bertin, MD, Isabel Sánchez-Ortega, MD PhD, Pablo Ramirez, MD, Mauricio Ocqueteau, MD, Beatriz Patiño, NG, Anna Sureda, MD PhD

Blood (2016) 128 (22): 2261.

https://doi.org/10.1182/blood.V128.22.2261.2261

Published: 2016

Journal Articles

Donor Lymphocyte Infusions for Haematological Malignancy Relapse

Guillermo Orti, MD, Irene García-Cadenas, MD, Isabel Sánchez-Ortega, MD PhD, Mª Jose Jimenez, MD, Laura Alonso, MD, Carmen Azqueta, PhD, Cristina Diaz de Heredia, MD, Cristelle Ferra, MD, Rocio Parody, MD PhD, Jorge Sierra, MD PhD, Sergio Querol, MD PhD, David Valcarcel, MD PhD

Blood (2016) 128 (22): 5775.

https://doi.org/10.1182/blood.V128.22.5775.5775

Published: 2016

Journal Articles

Prognostic Impact of Adverse Karyotype and Treatment in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Virginia Escamilla, Resident Physician, Jose Falantes, MD, Cristina Calderon, MD, Jose Gonzalez Campos, MD, Rosario Morales Camacho, MD PhD, Isabel Montero, MD, Rocio Parody, MD PhD, Ricardo Bernal, MD PhD, Ildefonso Espigado, MD PhD, Jose A Perez-Simón, MD PhD

Blood (2015) 126 (23): 5241.

https://doi.org/10.1182/blood.V126.23.5241.5241

Published: 2015

Journal Articles

Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation

Sarmiento Mauricio, MDPhD, Ildefonso Espigado, MD PhD, Rocio Parody, MD, Francisco Marquez, NR, Jose Falantes, MD, Teresa Caballero, PhD, Cristina Calderon, MD, Magdalena Carmona, MDPhD, Jose Lopez, MDPhD, Jose A. Perez-Simon, MD, PhD

Blood (2015) 126 (23): 4363.

https://doi.org/10.1182/blood.V126.23.4363.4363

Published: 2015

Journal Articles

An International Multicenter Comparative Analysis of Tacrolimus Plus Sirolimus with or without Antithymocyte Globulin As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Allogeneic Hematopoietic Cell Transplantation

Mohamed A. Kharfan-Dabaja, MD, Rocio Parody, MD, Janelle Perkins, PharmD, Oriana Lopez-Godino, MD, Lucia Lopez-Corral, MD, Lourdes Vazquez, MD, Dolores Caballero, MD, Jose Falantes, MD, Jamie Shapiro, PharmD, Guillermo Orti, MD, Pere Barba, MD, David Valcárcel, MD PhD, Alber Esquirol, MD, Rodrigo Martino, MD PhD, Jose Luis Piñana, MD, Carlos Solano, MD, Joseph A Pidala, MD, PhD, Claudio Anasetti, MD, Jose A. Perez-Simon, MD, PhD

Blood (2015) 126 (23): 3142.

https://doi.org/10.1182/blood.V126.23.3142.3142

Published: 2015

Journal Articles

Association Between Uric Acid Levels and Severe Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation

Nuria Martinez-Cibrian, Teresa Garrido, Arturo Pereira, Mauricio Sarmiento, Jose Antonio Pérez-Simón, Rocio Parody, MD, Estefania Perez, Oriana Lopez, Carlos Solano, Jose Luis Piñana, Montserrat Rovira, Francesc Fernandez-Avilés, Maria Suarez-Lledo, Alvaro Urbano-Ispizua, Carmen Martinez, MD PhD

Blood (2015) 126 (23): 5464.

https://doi.org/10.1182/blood.V126.23.5464.5464

Published: 2015

Journal Articles

Strategies for Graft Versus Host Disease Prophylaxis after Reduced-Intensity Conditioning Transplantation: Combination of Sirolimus Plus Tacrolimus Allows to Obtain the Best Outcome

Rocío Parody, MDPhD, Dolores Caballero, Martinez Carmen, MD PhD, Rodrigo Martino, MD PhD, Carlos Solano, Pere Barba, MD, Lucía López-Corral, MD PhD, Oriana Lopez Godino, MD, Lourdes Vazquez, MD, Montserrat Rovira, MD PhD, Francesc Fernandez-Avilés, Albert Esquirol, MD, Irene García Cadenas, José Luís Piñana, David Valcarcel, MD PhD, Francisco J. Marquez-Malaver, Jose Antonio Perez-Simón, MDPhD

Blood (2014) 124 (21): 1165.

https://doi.org/10.1182/blood.V124.21.1165.1165

Published: 2014

Journal Articles

Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients

Fátima de la Cruz Vicente, MD, Maria Angeles Domiunguez Muñoz, MD, Estrella Carrillo Cruz, MD, José Francisco Márquez Malaver, Rocio Parody Porras, MD, Jose Francisco Falantes González, MD, Cristina Calderón Cabrera, MD, Olga Pérez López, MD, María Solé Rodríguez, MD, Jose González Campos, MD, María Isabel Montero Cuadrado, MD, María Luz Martino Galiana, MD, Jose Antonio Pérez-Simón, PhD, Ildefonso Espigado, PhD

Blood (2014) 124 (21): 3977.

https://doi.org/10.1182/blood.V124.21.3977.3977

Published: 2014

Journal Articles

The Presence Of 1 / 8 HLA Mismatch Do Not Hamper Survival After Allogeneic Stem Cell Transplantation Using Immunoprophylaxis With Sirolimus-Tacrolimus

Rocío Parody, MD, PhD, Lucía López-Corral, MD, PhD, Oriana Lopez Godino, MD, Irene García Cadenas, Vazquez Lourdes, MD, Rodrigo Martino, MD, PhD, Carmen Martinez, Carlos Solano, Ariadna Perez Martinez, Pere Barba, MD, David Valcarcel, MD, Jose F. Falantes, MD, Francisco J Márquez-Malaver, Dolores Caballero, MD, PhD, Jose Antonio Perez-Simón, MD, PhD

Blood (2013) 122 (21): 4529.

https://doi.org/10.1182/blood.V122.21.4529.4529

Published: 2013

Journal Articles

Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation

Cristina Calderón Cabrera, Jose F Falantes, MD, Marina Gómez, Rocío Parody, MD, PhD, Francisco J Márquez Malaver, María L Martino, José González, Isabel Montero, Ildefonso Espigado, Jose Antonio Pérez-Simón

Blood (2013) 122 (21): 2812.

https://doi.org/10.1182/blood.V122.21.2812.2812

Published: 2013

NARROW

Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

Allogeneic STEM Cell Transplantation in 45 Patients with Myelodysplastic Syndrome: Single-Center Analysis

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic

Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

A High Dose of Naïve CD8 + T-Cells Increases the Incidence of Graft-Versus-Host Disease (GvHD) after Donor Lymphocyte Infusions (DLIs) from HLA Identical Sibling Donors

Influence of VDR Polymorphisms on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) within the Alovita Trial.

Safety and Efficacy of Idelalisib Treatment of Chronic Lymphocytic Leukemia (CLL) or Lymphoma Relapsing after Allogeneic Hematopoietic Cell Transplantation (alloHCT): A Survey By the EBMT Chronic Malignancies and Lymphoma Working Parties

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Non-Cryopreserved Autologous Hematopoietic Transplantation Has Less Short Term Complications, Faster Engraftment and Similar Transplant Outcomes Than Cryopreserved Modality in Multiple Myeloma and Lymphoma Patients. a Comparative Analysis of Two Centers

Donor Lymphocyte Infusions for Haematological Malignancy Relapse

Prognostic Impact of Adverse Karyotype and Treatment in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Pronostic Value of Pretransplant Echocardiography in Allogeneic Hematopoietic Cell Transplantation

An International Multicenter Comparative Analysis of Tacrolimus Plus Sirolimus with or without Antithymocyte Globulin As Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Allogeneic Hematopoietic Cell Transplantation

Association Between Uric Acid Levels and Severe Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation

Strategies for Graft Versus Host Disease Prophylaxis after Reduced-Intensity Conditioning Transplantation: Combination of Sirolimus Plus Tacrolimus Allows to Obtain the Best Outcome

Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients

The Presence Of 1 / 8 HLA Mismatch Do Not Hamper Survival After Allogeneic Stem Cell Transplantation Using Immunoprophylaxis With Sirolimus-Tacrolimus

Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only